Concepedia

Publication | Closed Access

Phase I trial of subcutaneous recombinant macrophage colony-stimulating factor: clinical and immunomodulatory effects.

DOI

39

Citations

0

References

1994

Year

Ronald M. Bukowski, G. Thomas Budd, Jacqueline A. Gibbons, Robert J. Bauer, A Childs, Joyce Antal, James H. Finke, Laurie Tuason, Varenka Lorenzi, Denise McLain
Journal of Clinical Oncology

Abstract

rM-CSF can be safely administered to patients, and has biologic activity on peripheral-blood monocytes.